Acute myelogenous leukemia with t(6;9)(p23;q34): Report of three patients
スポンサーリンク
概要
- 論文の詳細を見る
- 1999-02-01
著者
-
MATSUI Hirotaka
Department of Internal Medicine, Hamamatsu University School of Medicine
-
FUJISAWA Shinya
Department of Medicine III, Hamamatsu University School of Medicine
-
Fujisawa Shinya
Department Of Hematology Hamamatsu Medical Center
-
Matsui Hirotaka
Department Of Hematology Hamamatsu Medical Center
-
Matsui Hirotaka
Department Of Developmental Biology And Molecular Oncology Research Institute For Radiation Biology
-
KOBAYASHI Masahide
Department of Hematology, Hamamatsu Medical Center
-
Kobayashi Masahide
Department Of Hematology Hamamatsu Medical Center
-
YANO Kunio
Department of Hematology, Hamamatsu Medical Center
-
NAKANO Yasuyuki
Department of Hematology, Hamamatsu Medical Center
-
ABE Miki
Department of Hematology, Hamamatsu Medical Center
-
Abe Miki
Department Of Hematology Hamamatsu Medical Center
-
Yano Kunio
Department Of Infectious Diseases Hamamatsu Medical Center
-
Yano Kunio
Department Of Hematology Hamamatsu Medical Center
-
Nakano Yasuyuki
Department Of Hematology Hamamatsu Medical Center
-
Kobayashi Masahide
Department Of Chemistry Graduate School Of Science And Engineering University Of Toyama
-
Kobayashi Masahide
Department Of Anatomic And Diagnostic Pathology Dokkyo University School Of Medicine
-
YANO KUNIO
Department of Environmental Hygiene, Kurume University School of Medicine
-
YANO KUNIO
Department of Environmental H ygiene, Kurume University School of Medicine
関連論文
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Spicamycin and KRN5500 Induce Apoptosis in Myeloid and Lymphoid Cell Lines with Down-regulation of Bcl-2 Expression and Modulation of Promyelocytic Leukemia Protein
- A variant transcript, e1a3, of the minor BCR-ABL fusion gene in acute lymphoblastic leukemia : case report and review of the literature
- Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Acute myelogenous leukemia with t(6;9)(p23;q34): Report of three patients
- Emergence of Nonalbicans Candida Species Immunocompromised Leukemia Patients during Fluconazole Treatment
- Ras-mediated Up-regulation of Survivin Expression in Cytokine-dependent Murine Pro-B Lymphocytic Cells
- A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
- Synthesis and Absolute Structure of (-)-Umtatin
- Superior Efficacy of MMCP Regimen Compared with VMCP and MMPP Regimens in the Treatment of Multiple Myeloma
- Posttreatment M-Protein Nadir Level Is a Significant Prognostic Factor Associated with Survival in Multiple Myeloma
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Plasma Cell Leukemia with Lobulated Nuclei : One Case Report
- Molecular remission achieved by interferon therapy in a patient with cytogenetically relapsed chronic myelogenous leukemia after syngeneic bone marrow transplantation
- CD7/CD19 Double-Positive T-Cell Acute Lymphoblastic Leukemia
- Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
- CD4- and CD56-positive T-cell line MTA, established from natural killer-like T-cell leukemia/lymphoma
- Post-transplant plasmacytoma without Epstein-Barr virus infection occurring rapidly after unrelated allogeneic bone marrow transplantation
- CD5^+ Diffuse Large B-Cell Lymphoma with c-myc/IgH Rearrangement Presenting as Primary Effusion Lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Clinical Evaluation of Monotherapy with Cefpirome for Infections Complicating Hematological Disorders
- Superior Efficacy of MMCP Regimen Compared with VMCP and MMPP Regimens in the Treatment of Multiple Myeloma
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Formation of Pr Oxide Films by Atomic Layer Deposition Using Pr(EtCp)3 Precursor
- POPULATION CHANGES AMONG AGED PEOPLE IN THE PREFECTURE OF LONG LIFE AND IN THAT OF SHORT LIFE
- AN ANALYTICAL STUDY OF THE GROWTH CURVE
- AN ANALYTICAL STUDY OF ROHRER INDEX CURVE
- AN ANALYTICAL STUDY ON THE ANNUAL PHYSICAL GROWTH OF SCHOOL CHILDREN IN JAPAN